Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Enterprise Financial Services | EFSC | Apr 26, 2024 | 38.80 | -0.23 |
Enterprise Financial Services A Pref | EFSCP | Apr 26, 2024 | 19.35 | +1.55 |
Enterprise Products Partners LP Unit | EPD | Apr 26, 2024 | 29.06 | +0.45 |
Entrada Therapeutics | TRDA | Apr 26, 2024 | 12.45 | +0.73 |
Entravision Communications | EVC | Apr 26, 2024 | 2.09 | -0.48 |
Envela | ELA | Apr 26, 2024 | 4.38 | +1.39 |
Enveric Biosciences | ENVB | Apr 26, 2024 | 0.90 | -0.56 |
Envestnet | ENV | Apr 26, 2024 | 62.15 | -0.34 |
Enviri | NVRI | Apr 26, 2024 | 8.09 | +0.50 |
Environmental Svcs ETF Market Vectors | EVX | Apr 26, 2024 | 162.37 | -0.43 |
Envirotech Vehicles | EVTV | Apr 26, 2024 | 2.29 | -0.74 |
Envista | NVST | Apr 26, 2024 | 20.39 | +1.85 |
Enviva | EVA | Apr 26, 2024 | 0.54 | -0.57 |
Envoy Medical A | COCH | Apr 26, 2024 | 5.18 | +2.37 |
enVVeno Medical | NVNO | Apr 26, 2024 | 5.18 | -0.96 |
Enzo Biochem | ENZ | Apr 26, 2024 | 1.05 | -1.87 |
EOG Resources | EOG | Apr 26, 2024 | 135.70 | +0.25 |
Eos Energy Enterprises | EOSE | Apr 26, 2024 | 0.81 | +7.71 |
EPAM Systems | EPAM | Apr 26, 2024 | 237.75 | +0.26 |
EpicQuest Eduaction Group | EEIQ | Apr 26, 2024 | 0.99 | +7.40 |
ePlus | PLUS | Apr 26, 2024 | 78.19 | +0.53 |
EPR Properties | EPR | Apr 26, 2024 | 40.99 | -0.32 |
EPR Properties Pref C | EPR-C | Apr 26, 2024 | 18.91 | -0.21 |
EPR Properties Pref E | EPR-E | Apr 26, 2024 | 27.44 | -0.58 |
EPR Properties Pref G | EPR-G | Apr 26, 2024 | 18.98 | -0.11 |
Epsilon Energy | EPSN | Apr 26, 2024 | 5.43 | -0.37 |
EQT | EQT | Apr 26, 2024 | 40.61 | +0.49 |
Equifax | EFX | Apr 26, 2024 | 223.42 | -1.26 |
Equillium | EQ | Apr 26, 2024 | 1.71 | -5.52 |
Equinix | EQIX | Apr 26, 2024 | 731.61 | -0.91 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.